FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078495613> ?p ?o ?g. }

• W2078495613 endingPage "438" @default.
• W2078495613 startingPage "431" @default.
• W2078495613 abstract "The triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic Acid (CDDO, previously RTA 401) is a multifunctional molecule that controls cellular growth and differentiation. While CDDO is capable of activating the transcription factor peroxisome proliferator activator receptor-γ (PPARγ), its apoptotic effects in malignant cells have been shown to occur independently of PPARγ. A phase I dose-escalation study was conducted to determine the toxicity, the maximum tolerated dose, and the pharmacokinetics and pharmacodynamics of CDDO, administered as a 5-day continuous infusion every 28 days in patients with advanced cancers. An accelerated titration design was followed, with one patient per cohort entered, and doses ranging from 0.6 to 38.4 mg/m2/h. Pharmacokinetics of CDDO was assessed and cleaved poly (ADP-ribose) polymerase (c-PARP), as a marker of apoptosis, was measured in peripheral blood mononuclear cells to assess drug effect. Seven patients, one patient per dose level up to dose level 7 (38.4 mg/m2/h), were enrolled and received a total of 11 courses of treatment. Cmax increased proportionally with dose. Preclinically determined efficacious blood level (1 μM) of drug was attained at the highest dose level. One patient, at dose level 6, experienced grade 2 mucositis, nausea, vomiting, and anorexia. Four patients developed thromboembolic events subsequently considered as dose-limiting toxicity. No antitumor activity was noted. A causal relationship of observed thromboembolic events to CDDO was considered possible but could not be established." @default.
• W2078495613 created "2016-06-24" @default.
• W2078495613 creator A5003847273 @default.
• W2078495613 creator A5010900558 @default.
• W2078495613 creator A5011974968 @default.
• W2078495613 creator A5021892503 @default.
• W2078495613 creator A5022339242 @default.
• W2078495613 creator A5025748236 @default.
• W2078495613 creator A5026863845 @default.
• W2078495613 creator A5026986071 @default.
• W2078495613 creator A5041170114 @default.
• W2078495613 creator A5041200743 @default.
• W2078495613 creator A5045409088 @default.
• W2078495613 date "2011-07-31" @default.
• W2078495613 modified "2023-10-07" @default.
• W2078495613 title "Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors" @default.
• W2078495613 cites W1804620564 @default.
• W2078495613 cites W1974468042 @default.
• W2078495613 cites W1977693378 @default.
• W2078495613 cites W1977773503 @default.
• W2078495613 cites W1978256546 @default.
• W2078495613 cites W1989852705 @default.
• W2078495613 cites W1994637501 @default.
• W2078495613 cites W1998073384 @default.
• W2078495613 cites W1998505999 @default.
• W2078495613 cites W2014208902 @default.
• W2078495613 cites W2024823380 @default.
• W2078495613 cites W2047815869 @default.
• W2078495613 cites W2061957745 @default.
• W2078495613 cites W2081488575 @default.
• W2078495613 cites W2093534329 @default.
• W2078495613 cites W2106204758 @default.
• W2078495613 cites W2113309935 @default.
• W2078495613 cites W2126469731 @default.
• W2078495613 cites W2133862322 @default.
• W2078495613 cites W2139248078 @default.
• W2078495613 cites W2141086589 @default.
• W2078495613 cites W2147354436 @default.
• W2078495613 cites W2149562718 @default.
• W2078495613 cites W2154102072 @default.
• W2078495613 cites W2169093711 @default.
• W2078495613 cites W2180726212 @default.
• W2078495613 doi "https://doi.org/10.1007/s00280-011-1712-y" @default.
• W2078495613 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4490274" @default.
• W2078495613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21805353" @default.
• W2078495613 hasPublicationYear "2011" @default.
• W2078495613 type Work @default.
• W2078495613 sameAs 2078495613 @default.
• W2078495613 citedByCount "23" @default.
• W2078495613 countsByYear W20784956132012 @default.
• W2078495613 countsByYear W20784956132013 @default.
• W2078495613 countsByYear W20784956132014 @default.
• W2078495613 countsByYear W20784956132015 @default.
• W2078495613 countsByYear W20784956132016 @default.
• W2078495613 countsByYear W20784956132017 @default.
• W2078495613 countsByYear W20784956132019 @default.
• W2078495613 countsByYear W20784956132021 @default.
• W2078495613 crossrefType "journal-article" @default.
• W2078495613 hasAuthorship W2078495613A5003847273 @default.
• W2078495613 hasAuthorship W2078495613A5010900558 @default.
• W2078495613 hasAuthorship W2078495613A5011974968 @default.
• W2078495613 hasAuthorship W2078495613A5021892503 @default.
• W2078495613 hasAuthorship W2078495613A5022339242 @default.
• W2078495613 hasAuthorship W2078495613A5025748236 @default.
• W2078495613 hasAuthorship W2078495613A5026863845 @default.
• W2078495613 hasAuthorship W2078495613A5026986071 @default.
• W2078495613 hasAuthorship W2078495613A5041170114 @default.
• W2078495613 hasAuthorship W2078495613A5041200743 @default.
• W2078495613 hasAuthorship W2078495613A5045409088 @default.
• W2078495613 hasBestOaLocation W20784956132 @default.
• W2078495613 hasConcept C111113717 @default.
• W2078495613 hasConcept C112705442 @default.
• W2078495613 hasConcept C126322002 @default.
• W2078495613 hasConcept C22979827 @default.
• W2078495613 hasConcept C2778496288 @default.
• W2078495613 hasConcept C2780580376 @default.
• W2078495613 hasConcept C2780852908 @default.
• W2078495613 hasConcept C29730261 @default.
• W2078495613 hasConcept C71924100 @default.
• W2078495613 hasConcept C90924648 @default.
• W2078495613 hasConcept C98274493 @default.
• W2078495613 hasConceptScore W2078495613C111113717 @default.
• W2078495613 hasConceptScore W2078495613C112705442 @default.
• W2078495613 hasConceptScore W2078495613C126322002 @default.
• W2078495613 hasConceptScore W2078495613C22979827 @default.
• W2078495613 hasConceptScore W2078495613C2778496288 @default.
• W2078495613 hasConceptScore W2078495613C2780580376 @default.
• W2078495613 hasConceptScore W2078495613C2780852908 @default.
• W2078495613 hasConceptScore W2078495613C29730261 @default.
• W2078495613 hasConceptScore W2078495613C71924100 @default.
• W2078495613 hasConceptScore W2078495613C90924648 @default.
• W2078495613 hasConceptScore W2078495613C98274493 @default.
• W2078495613 hasIssue "2" @default.
• W2078495613 hasLocation W20784956131 @default.
• W2078495613 hasLocation W20784956132 @default.
• W2078495613 hasLocation W20784956133 @default.
• W2078495613 hasLocation W20784956134 @default.
• W2078495613 hasOpenAccess W2078495613 @default.

• next